Abstract:ID 95376 Poster Board 503 Cannabinoids offer a promising analgesic treatment option for a variety of pain conditions, but their chronic use leads to the development of tolerance to the antinociceptive effects, posing a problem to their utilization as an effective long-term therapeutic. Agonist-induced internalization of cannabinoid receptor 1 (CB1R) is a crucial component in regulating signal transduction and the C-terminus tail of CB1R serves as a regulatory domain for internalization. Six point mutant (6PM) mice express serine/threonine to alanine point mutations for six putative G protein-coupled receptor kinase (GRK) phosphorylation sites in the C-terminus tail of CB1Rs that are necessary for internalization, thereby making the CB1Rs unable to efficiently undergo internalization, trafficking, and resensitization. The objective of this study is to investigate the effect of CB1R internalization on sensitivity to the acute antinociceptive and hypothermic effects of cannabinoid agonists as well as assessing recognition memory and motor coordination in 6PM mice expressing an internalization-deficient form of CB1R. A cumulative dose response curve was used to assess the acute response to CP55,940, a strongly internalizing cannabinoid agonist. Antinociception was measured using the tail-flick test and cannabinoid-induced hypothermia was examined by recording core body temperature. Motor coordination was assessed using the rotarod test where the latency to fall was measured. Recognition memory was evaluated using the novel object recognition (NOR) test where novel object recognition was determined by measuring time exploring a familiar versus a novel object placed in the test arena. 6PM mice show decreased antinociceptive and hypothermic responses to the effects of CP55,940 compared to wild-type controls. 6PM mice also displayed a decrease in recognition memory by spending more time exploring the familiar object, rather than the novel object in the novel object recognition test relative to wild-type controls. There were no differences between wild-type and 6PM mice in the average time spent on the rotarod. Data from this study demonstrate that the antinociceptive and hypothermic effects of CP55,940 were reduced in the 6PM mice suggesting that CB1R internalization, trafficking, and recycling may be important components involved in the response to cannabinoids. This data also shows that six point mutant mice have a lower recognition memory, indicating a possible role for CB1R internalization in cognitive processes. Overall, these results suggest that internalization may be a critical regulator of responses to cannabinoids as well as playing a role in memory formation and recall pathways. Acknowledgements Funded by NIH grant DA044999 and the NASA West Virginia Space Grant Consortium, Grant # 80NSSC20M0055.

Indirect and direct cannabinoid agonists differentially affect mesolimbic dopamine release and related behaviors.

Robust aversive effects of trace amine-associated receptor 1 activation in mice

Behavioral and neurochemical changes in mesostriatal dopaminergic regions of the rat after chronic administration of the cannabinoid receptor agonist WIN55,212-2

Cannabidiol but not cannabidiolic acid reduces behavioural sensitisation to methamphetamine in rats, at pharmacologically effective doses

Effect of MCH1, a fatty-acid amide hydrolase inhibitor, on the depressive-like behavior and gene expression of endocannabinoid and dopaminergic-signaling system in the mouse nucleus accumbens

Therapeutic‐like activity of cannabidiolic acid methyl ester in the MK‐801 mouse model of schizophrenia: Role for cannabinoid CB1 and serotonin‐1A receptors

Impact of Cannabinoid Type 1 Receptor Modulation on Risky Decision-Making

Differential Effects of Drug-Induced Ascorbic Acid Release in the Striatum and Nucleus Accumbens of Freely Moving Rats

Counteractive effects of cannabinoid and nicotine-addictive behavior.

The impact of piperazine and antipsychotic co-exposures and CB1 blockade on the effects elicited by AMB-FUBINACA, a synthetic cannabinoid, in mice.

Central cholinergic transmission modulates endocannabinoid-induced marble-burying behavior in mice

Cannabidiol Plays a Modulatory Function on the Methamphetamine-Induced Reward Through Hippocampal D2-Like Dopamine Receptors

Cannabinoid receptor 1 positive allosteric modulator ZCZ011 shows differential effects on behavior and the endocannabinoid system in HIV-1 Tat transgenic female and male mice

Acute Cannabinoids Produce Robust Anxiety-Like and Locomotor Effects in Mice, but Long-Term Consequences Are Age- and Sex-Dependent

Mice expressing an Internalization-Resistant form of CB1R exhibit altered responses to Cannabinoids and impaired Recognition Memory

Bi-directional cannabinoid signalling in the basolateral amygdala controls rewarding and aversive emotional processing via functional regulation of the nucleus accumbens

Differential cannabinoid‐like effects and pharmacokinetics of ADB‐BICA, ADB‐BINACA, ADB‐4en‐PINACA and MDMB‐4en‐PINACA in mice: A comparative study

Cannabinoid type-1 receptor signaling in dopaminergic Engrailed-1 expressing neurons modulates motivation and depressive-like behavior

Negative allosteric modulation of CB1 cannabinoid receptor signaling decreases intravenous morphine self-administration and relapse in mice

The role of D1-like dopamine receptors within the ventral tegmental area in the cannabidiol's inhibitory effects on the methamphetamine-induced conditioned place preference in rats